ReleaseWire Connect

Building Integrated Photovoltaic is one of the promising renewable energy technologies that help in onsite production of electricity. BIPV technology generates electricity from the sunlight without depleting natural resources .For the last few years, Photovoltaic (PV) elements are integral part of the building constructions, as demand of solar electric architecture is rising. Lack of natural resources such as gas and oil are some of the driving forces to adopt BIPV technology in various construction applications. Increasing trend of green and "Leadership in Energy and Environment Design (LEED)" also helps in increasing the adoption of BIPV as a long-term management option.

Global Battery technology market includes primary batteries used in electronic keys, watches, remote controls, toys etc. and secondary batteries used in automotives & aviation and portable & stationery batteries. The global advanced energy storage system market is expected to attain market revenue of $10.8 billion by 2018 at a CAGR of 10% between 2013 and 2018. The battery technology market is a key constituent of the advanced energy storage system market; therefore, the market is expected to have a sustainable growth rate. It is estimated that there would be 40% increase in demand for electricity between 2010 and 2040. The ever increasing demand for electricity is one of the prime drivers for the market as power can be efficiently stored in the batteries.

Encapsulation is the process of incorporating food ingredients, enzymes and other materials into capsules. The parent market for the Encapsulated food is the global food market, which was $4200 billion in 2012. The awareness of health, demand for convenience food and busy schedules are the major driving factors of the encapsulated food market. The limiting factors of this market are the maintenance of stability of the food during the processing and packaging. The other limiting factor is the size of the capsule. The opportunities of this market are the ongoing high investments due to demand for food that helps in preventing health problems and aging population.

Biopharmaceuticals are drugs produced from genetically modified source, which are mainly proteins and nucleic acids. According to IMS Health Market Prognosis, the total market size of pharmaceutical industry was approximately $962.1 billion in 2012. The market for the Biopharmaceuticals drug was $149 billion in 2010. The factors driving the market are, increase in regulatory approvals for biotechnology products. One such product is the recombinant DNA-based products, which has high rates of approval from regulatory authorities. The opportunities of this market are the ageing population and increase in the number of diseases. The challenges of this market are the reimbursement and pricing policy that are the limiting factors in the launch of high priced drugs.

The Bio renewable chemical is a concept of "green chemistry", which uses natural renewable source of energy to produce certain chemicals. Now a days, companies and governments around the world are emphasizing on environmentally friendly business. In addition to that, scarcity of non-renewable resources also attracts stakeholders towards bio-renewable chemical market. Increase in demand for fossil fuels leads to increase in price of fuel related products and hence, to decrease this dependency, the demand for bio renewable chemicals is increasing. For example, increase in demand for polylactic acid (PLA), bioethylene and polyhydroxyalkanoate (PHA) would depreciate the demand for fossil fuels over the long run. The global market for bio-renewable chemicals is hampered due to unavailability or scarcity of raw materials used in production of renewable chemicals. The global market for bio renewable chemicals is facing challenges in availing cost effective raw material due to its generic applications. However, governments and private organizations are granting reimbursements to promote the production of raw materials.

Plastic healthcare packaging is a practice of securely packaging of devices, tools, drugs and other healthcare products. The global market for Plastic healthcare packaging is expected to reach $87.3 billion in 2011. Increase in demand for healthcare practices promotes the growth for healthcare packaging market. Developed countries are engaged in development of healthcare services that increase the investment on healthcare packaging. Increase in counterfeiting practice in pharmaceutical industries is affecting the growth of plastic healthcare packaging market. However, Asian countries are highly affected by counterfeiting of pharmaceutical products, especially in non-prescribed drugs. The healthcare packaging market is constantly challenged by shifting trends such as the increased use of disposable medical products, an ageing population, outsourcing packaging, child-resistant and tamper-evident packaging. In order to overcome on the challenges of counterfeiting U.S. government passed the Track and Trace Bill under which Drug Quality and Security Act (DQSA) has been issued. DQSA act implemented electronic tracking for food and pharmaceutical packaging. This report provides intelligence about key legislation and regulation according to geographies. Key market trends available for plastic healthcare packaging.

The Microfluidics market provides practical application of small fluid volumes for design of systems and development of solutions. The global healthcare technology market is estimated to reach $53 billion by 2014 at a CAGR of 16%. Microfluidics is an emerging technology with growing acceptability in healthcare applications. The key driver for the microfluidics market is the –great (or rising) demand in point-of-care (POC) and in-vitro diagnostics. For example, according to World Health Organization (WHO), 95 million people received HIV testing in low and middle-income countries in 2010. Application of microfluidics in HIV testing at POCs is expected to cut cost, thereby increase the demand for the technology.

Therapeutic vaccines are provided to the body during treatment of specific diseases. This vaccine triggers and strengthens the immune response of the body to act against a disease. In 2011, the global Therapeutic vaccines market was valued at $294 million. This vaccine has expanded the horizon of chronic disease treatment. However, there is a need to get a vaccine for specific disease to be approved by the FDA. Increasing cases of chronic diseases and need for effective treatment is acting as key driver for this market. Various pharmaceutical companies are working to develop novel vaccines for diseases such as lung cancer, breast cancer, Alzheimer, etc. However, these vaccine developments are in pipeline and yet to be commercialized.

Atomic layer deposition is a deposition technique that uses thin film that is based on sequential use in gas phase process. The global materials industry has a 38.5% CAGR and is expected to reach $400 million in 2015.One of the major factors for the growth of this market can be the growing use of component miniaturization. The market for component miniaturization is expected to grow to $21.1 billion till 2016.The high investment cost acts as a restraining factor for growth of Atomic layer deposition market. Many manufacturing companies prefer ALD technique to produce smaller components.

Fuel cells are devices that convert chemical energy into electrical energy through series of chemical reactions. Total investment through venture capital and private equity investment in Fuel cell companies in US accounted to $389.4 million between 2009 and 2011. Increase in need for zero emission energy sources and environmental awareness are driving the fuel cell market. More than 34 companies produced 30 plus MW of stationary power in 2011. The total shipment of fuel cells increased approximately from 16,000 units in 2010 to 22,000 unit in 2011. High cost of fuel cells and cost associated with infrastructure establishment are barriers for the growth of this market,